17/06/2026
. Late last year we hosted an expert panel discussion focused on the utility of Cxbladder Triage in the evaluation of patients with microhematuria. In this mini-clip, taken from the 50min session, Dr. Jhaveri and Dr. Goldfischer discuss the use of Cxbladder to help optimize practice workflow, prioritizing those who require care: https://hubs.la/Q04lMT1r0
View the full webinar: https://hubs.la/Q04lMZwx0
==
Cxbladder Triage is a non-invasive genomic urine test optimized to risk stratify and rule out urothelial cancer in patients presenting with microhematuria. The test is included in the AUA/ SUFU Microhematuria Guideline, supported with Grade A evidence, and US Medicare coverage for the use of Triage and Triage Plus in appropriately counseled intermediate risk patients has been proposed with the recent publication of a draft LCD. Learn more: https://hubs.la/Q04lNqVt0